Geode Capital Management, LLC Regencell Bioscience Holdings LTD Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Geode Capital Management, LLC holds 391,066 shares of RGC stock, worth $5.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
391,066
Previous 6,816
5637.47%
Holding current value
$5.26 Million
Previous $217,000
2970.51%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RGC
# of Institutions
10Shares Held
417KCall Options Held
0Put Options Held
0-
Y Intercept (Hong Kong) LTD13KShares$175,2840.01% of portfolio
-
Greenfield Savings Bank11KShares$147,8400.09% of portfolio
-
Royal Bank Of Canada Toronto, A6948Shares$12,7410.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY698Shares$9,3810.0% of portfolio
-
Black Rock Inc. New York, NY238Shares$3,1980.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $175M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...